REFERENCES
- Constantinides P. P., Yiv S. H. Particle size determination of phase-inverted water-in-oil emulsions under different dilution and storage conditions. Int. J. Pharm. 1995; 115: 225–234
- Cui Z, Mumper R. J. Intranasal administration of plasmid DNA-coated nanoparticles results in enhanced immune responses. J Pharm Pharmacol. 2002; 54: 1195–1203
- Danino D., Talmon Y., Zana R. Vesicle-to-micelle transformation in systems containing dimeric surfactants. J. Colloid. Interface. Sci. 1997; 185: 84–93
- Fei H., Sanming L., Ran Y., Hongzhuo L., Lu X. Effect of surfactants on the formation and characterization of a new type of colloidal drug delivery system: Nanostructured lipid carriers. Colloids Surf. A: Physicochem. Eng. Aspects. 2008; 315: 210–216
- Fry D. W., White J. C., Goldman I. D. Rapid separation of low molecular weight solutes from liposomes without dilution. J. Anal. Biochem. 1978; 90: 809–815
- FuQiang H. Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloids Surf. B: Biointerfaces 2005; 45: 167–173
- Hiemenz P. C., Rajagopalan R. Principles of colloidal and surface chemistry3rd. Marcel Dekker, New York 1997; 270–271
- Jenning V., Gohla S. Encapsulation of retinoids in solid lipid nanoparticles (SLN). J. Microencaps. 2001; 18: 149–158
- Jenning V., Schäfer-Korting M., Gohla S. Vitamin A-loaded solid lipid nanoparticles for topical use: Drug release properties. J. Control. Release. 2000; 66(2)115–126
- Kitagawa H., Sakai T., Saito H., Mori M., Tazoe R., Sugibayashi T., Nomura A. Anti-inflammatory and analgesic actions and skin irritation of flurbiprofen by dermal application. Lyakuhin Kenkyu. 1993; 13: 869–878
- Kyuki K., Tsurumi K., Fujimura H., Masumoto S., Hashimoto Y. Anti-inflammatory effect of flurbiprofen for dermal application (FP-A). Iyakuhin Kenkyu. 1984; 15: 293–298
- Lee D. J., Burt C. T., Koch R. L. Percutaneous absorption of flurbiprofen in the hairless rat measured in vivo using 19F magnetic resonance spectroscopy. J. Invest. Dermatol. 1992; 99: 431–434
- Masumoto S., Akiba T., Okumura M., Ichikawa K., Hashimoto Y. Anti-inflammatory effect of flurbiprofen by topical application. Iyakuhin Kenkyu. 1982; 13: 878–885
- McNeill S. C., Potts R. O., Francoeur M. L. Local enhanced topical delivery (LETD) of drugs: Does it truly exist?. Pharm. Res. 1992; 9: 1422–1427
- Müller R. H., Mehnert W., Lucks J. S., Schwarz C., zur Mühlen A., Weyhers H., Freitas C., Rühl D. Solid lipid nanoparticles (SLN)-an alternative colloidal carrier system for controlled drug delivery. Eur. J. Pharm. Biopharm. 1995; 41(1)62–69
- Müller B. W., Müller R. H. Particle size distributions and particle size alterations in microemulsions. J. Pharm. Sci. 1984; 73(7)919–922
- New R. R. C. Liposomes: A practical approach. Oxford University Press, Oxford 1990
- Poul J., West J., Buchanan N., Grahame R. Local action transcutaneous flurbiprofen in the treatment of soft tissue rheumatism. Br. J. Pharmatol. 1993; 32: 1000–1003
- Radomska S. A., Müller R. H. Chemical stability of lipid excipients in SLN-production of test formulations, characterization and short-term stability. Pharmazie. 2006; 61(5)431–437
- Reich G. In vitro stability of poly (D, L-lactide) and poly (D, L-lactide)/ poloxamer nanoparticles in gastrointestinal fluids. Drug. Dev. Ind. Pharm. 1997; 23(12)1191–1198
- Santos Maia C., Mehnert W., Schäfer-Korting M. Solid lipid nanoparticles as drug carriers for topical glucocorticoids. Int. J. Pharm. 2000; 196(2)165–167
- Siekmann B., Westesen K. Melt-homogenized solid lipid nanoparticles stabilized by the nonionic surfactant tyloxapol I. Preparation and particle size determination. Pharm. Pharmacol. Lett. 1994; 3: 194–197
- Souto E. B., Müller R. H. The use of SLN and NLC as topical particulate carriers for imidazole antifungal agents. Pharmazie. 2006a; 61(5)431–437
- Souto E. B., Müller R. H. Investigation of the factors influencing the incorporation of clotrimazole in SLN and NLC prepared by hot high-pressure homogenization. J Microencapsul. 2006b; 23(4)377–388
- Souto E. B., Wissing S. A., Barbosa C. M., Müller R. H. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int. J. Pharm. 2004; 27: 71–77
- Wissing S. A., Lippacher A., Müller R. H. Investigations on the occlusive properties of solid lipid nanoparticles (SLN). J. Cosmet. Sci. 2001; 52: 313–323